$1.680
-0.039 (-2.33%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ENGN por análisis de gráficos similares
Alphio's ENGN stock price prediction model matches the current enGene Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.65 (-1.62%). The 1-week path is $1.65 (-1.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de enGene Therapeutics Inc?
enGene Holdings Inc is not a good buy right now due to significant financial losses and negative analyst sentiment. The current price is $1.45, which is 88.2% below its 52-week high of $12.25, indicating a substantial decline. Additionally, the RSI is at 23.7, suggesting the stock is oversold, but this could reflect ongoing issues rather than a buying opportunity. The company reported a net loss of $30.23 million in Q2 2026, which is wider than the previous year's loss, and its forward P/E ratio is 0, indicating no expected earnings growth. The main risk is the recent downgrade by Morgan Stanley, which has reduced its price target to $1, reflecting low confidence in the company's future performance.
ENGN cerró en $1.68 el Thursday, tras bajar -2.33%
enGene Therapeutics Inc (ENGN) last closed at $1.6799999, losing -2.33%. These facts feed the 1-day and 1-week ENGN price prediction above.
Factores de la previsión
Los factores de la previsión de enGene Therapeutics Inc (ENGN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ENGN, ordenadas por similitud.
Análisis de estacionalidad de ENGN
Historically the probability of a positive November return for ENGN is 20.45%. February offers the highest probability of a positive month at 51.72%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ENGN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $3.22 | $3.38 | $4.04 | +101.34% |
| Dec 2026 | $3.67 | $4.26 | $4.68 | +153.85% |
En 2026, se proyecta que enGene Therapeutics Inc (ENGN) oscile entre $3.22 y $4.68.
Previsión mensual de enGene Therapeutics Inc para 2026
En Nov de 2026, se proyecta que enGene Therapeutics Inc promedie $3.38, con un mínimo de $3.22 y un máximo de $4.04.
En Dec de 2026, se proyecta que enGene Therapeutics Inc promedie $4.26, con un mínimo de $3.67 y un máximo de $4.68.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.